Skip to menu Skip to content Skip to footer
  • UQ Home
  • Contacts
  • Study
  • Maps
  • News
  • Events
  • Library
  • Give now
  • my.UQ
The University of Queensland
Diamantina Institute Diamantina Institute
Site search
Site search
Menu
  • Home
  • About
    • News
    • Our people
    • History
    • Our supporters
    • The Translational Research Institute
    • Events
  • Research
    • Research themes
    • Research centres
    • Research by disease
    • Facilities and support services
    • Innovation and commercial development
  • Study
    • Undergraduate
    • Honours
    • Higher Degree by Research
    • Scholarships
    • Visiting Research Students
    • Why should I do my research project at UQDI?
  • Laboratory to patient
    • Clinical trials
    • Clinical research facilities
  • Community and alumni
    • SPARQ-ed
  • Donate now
  • Contact

Mrs Estelle Llamosas

Laboratory Manager
The University of Queensland Diamantina Institute
e.llamosas@uq.edu.au
Estelle Llamosas

Publications

Journal Articles (6)
Conference Papers (2)

Journal Articles

Ma, Sean S. Q., Henry, Claire E., Llamosas, Estelle, Higgins, Rupert, Daniels, Benjamin, Hesson, Luke B., Hawkins, Nicholas J., Ward, Robyn L. and Ford, Caroline E. (2017). Validation of specificity of antibodies for immunohistochemistry: the case of ROR2. Virchows Archiv, 470 (1), 99-108. doi: 10.1007/s00428-016-2019-5
Ma, Sean S. Q., Henry, Claire E., Llamosas, Estelle, Higgins, Rupert, Daniels, Benjamin, Hesson, Luke B., Hawkins, Nicholas J., Ward, Robyn L. and Ford, Caroline E. (2016). Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2. Virchows Archiv, 469 (6), 717-717. doi: 10.1007/s00428-016-2036-4
Ma, Sean S. Q., Srivastava, Sameer, Llamosas, Estelle, Hawkins, Nicholas J., Hesson, Luke B., Ward, Robyn L. and Ford, Caroline E. (2016). ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration. BMC Cancer, 16 (1) 508, 508. doi: 10.1186/s12885-016-2576-7
Henry, Claire, Llamosas, Estelle, Knipprath-Meszaros, Alexandra, Schoetzau, Andreas, Obermann, Ellen, Fuenfschilling, Maya, Caduff, Rosemarie, Fink, Daniel, Hacker, Neville, Ward, Robyn, Heinzelmann-Schwarz, Viola and Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Oncotarget, 6 (37), 40310-40326. doi: 10.18632/oncotarget.5643
Henry, C., Quadir, A., Hawkins, N.J., Jary, E., Llamosas, E., Kumar, D., Daniels, B., Ward, R.L. and Ford, C.E. (2015). Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. Journal of Cancer Research and Clinical Oncology, 141 (2), 243-254. doi: 10.1007/s00432-014-1824-y
Ford, C. E., Punnia-Moorthy, G., Henry, C. E., Llamosas, E., Nixdorf, S., Olivier, J., Caduff, R., Ward, R. L. and Heinzelmann-Schwarz, V. (2014). The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecologic Oncology, 134 (2), 338-345. doi: 10.1016/j.ygyno.2014.06.004

Conference Papers

Henry, C. E., Knipprath-Meszaros, A. M., Llamosas, E., Schotzau, A., Obermann, E., Fink, D., Hacker, N., Ward, R. L., Heinzelmann-Schwarz, V. and Ford, C. E. (2015). Ror2 is a novel target of the Wnt signaling pathway involved in metastasis and chemotherapy resistance. 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015), Nice, France, 24 - 27 October 2015. London, United Kingdom: Lippincott Williams & Wilkins.
Ford, C. E., Henry, C. E., Llamosas, E., Djordjevic, A., Hacker, N. F., Heinzelmann-Schwarz, V. A. and Ward, R. L. (2014). Hear the Ror! the Role of WNT Signalling in Ovarian Cancer. 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, Australia, 8-11 November 2014. Philadelphia, USA: Lippincott, Williams & Wilkins.
© The University of Queensland
Enquiries: +61 7 3365 1111   |   Contact directory
ABN: 63 942 912 684   |   CRICOS Provider No: 00025B
Emergency
Phone: 3365 3333
Privacy & Terms of use   |   Feedback   |   Updated: 24 May 2022
Login